Market Tracker

04/23 3:08pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.03
Real-Time Quote
 +0.0506 / +5.14%
Today’s Change
0.78
Today|||52-Week Range
2.89
-10.78%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.98
Today’s open0.99
Day’s range0.98 - 1.04
Volume325,095
Average volume (3 months)542,971
Market cap$35.7M
Dividend yield--
Data as of 2:53pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio7.4
Price/Sales1.47
Price/Book6.80

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...-0.00-0.15%
ECTEEcho Therapeutics In...-0.01-0.31%
HTBXHeat Biologics Inc+0.08+1.31%
CTRVContraVir Pharmaceut...-0.10-5.32%
Data as of 2:53pm ET, 04/23/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts